20 articles
Comprehensive review examines peptides like BPC-157 and TB-500 for wound healing, muscle repair, and recovery optimization in orthopedic medicine.
ProcyanidinC1, a natural senolytic, selectively eliminates senescent cells in diabetic skin, dramatically improving wound healing in mouse models.
Explore the molecular mechanisms of cellular senescence and how p16/p21 pathways drive SASP production, plus cutting-edge senolytic drug targets.
A special issue overview surveys three decades of peptide-based materials research, spotlighting applications from drug delivery to regenerative medicine.
Scientists engineer high-PS procoagulant platelets that outperform thrombin and commercial hemostatic agents, even in antiplatelet-treated patients.
A novel bone-mimicking scaffold delivering low-dose rhBMP-2 achieved complete fracture union in 4 months in a medically complex elderly patient.
150-person trial tests whether PRP injections can reduce knee pain and improve function better than placebo in osteoarthritis patients.
Encapsulating PDRN in biodegradable nanoparticles dramatically extends its stability and accelerates wound closure in inflammatory models.
A comprehensive 2025 review compares corticosteroids, HA, PRP, BMAC, MSCs, and emerging gene therapies for knee osteoarthritis.
Military study tests regenerative PRP injections against placebo for facet joint pain in 91 participants.
BioNTech reports positive Phase 2 results for HER2-targeted cancer therapy, with FDA filing planned to compete with existing treatments.
New biomimetic scaffold combines cartilage and bone layers to effectively regenerate damaged joint tissue in animal studies.
Researchers engineer tissue-targeting lipid nanoparticles that precisely deliver mRNA and prime editing tools to lungs, liver, spleen, thymus, and bone.
Adipose-derived stem cells combined with platelet-rich plasma evaluated for treating moderate to severe knee osteoarthritis over 2 years.
Computational protein design produces potent GPCR-targeting miniproteins for pain, cancer, obesity, and migraine with in vivo efficacy.
A completed multicenter feasibility trial evaluates BTM, a novel biodegradable scaffold, for treating serious deep burn injuries.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Comprehensive review reveals how PRP's growth factors, immune cells, and exosomes work together to enhance tissue repair across multiple medical specialties.
Clinical trial tests platelet-rich plasma therapy for shoulder osteoarthritis in 91 patients over 5 months.
Breakthrough crystal technology enables transplanted insulin-producing cells to survive and function for a full year without traditional immunosuppression.
